Clinical Trial Update: The Effect of a Methylprednisolone Taper on Outcomes Following Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a methylprednisolone taper to improve outcomes after total knee arthroplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis of the Knee
• Knee Osteoarthritis
• Postoperative Pain

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: F. Johannes Plate | Conditions: Arthritis Knee, Knee Osteoarthritis | Phase 4 | Status: WITHDRAWN